Research Sites Sample Clauses

Research Sites. The research settings were Batanani junior secondary school in Mapoka and Ramoja junior secondary school in Ramokgwebana in the North East District of Botswana. Batanani catchment area includes Mapoka, Masukwane and Kgari villages while Ramoja catchment area covers Ramokgwebana, Moroka and Jakalasi No. 1 village. Some of these areas are between four to seven kilometers from the schools. Both the schools are “twelve streams,” that is they have four form three classes, four form two classes and four form one classes, hence the term “twelve streams.” Batanani is a boarding school while Ramoja is a day school. The schools were chosen because of their accessibility since one of them (Batanani) is located within the home village of one of the researchers. Xxxxxx also became ideal in the study since it is not far distanced from Batanani and it is one of the old schools within the North Eastern region, hence its rich history was considered very essential to the study. Selection of Participants As earlier reflected, this was a case study which involved a detailed examination of two different settings. Xxxxxx & Xxxxxx (2003) charge that under a case study researchers scout for possible places and people who may be subjects or possible sources of data and then cast a wide net in their attempt to judge the feasibility of the site or data source. One factor that determines the participation of subjects in a study is feasibility or willingness to participate in a study (Yin, 2003). The research data was collected through interviewing and observing participants. The interviews were carried out on a population of fifty eight participants that is Heads of departments (n =6), teachers (n =10), students (n =20), prefects (n =20) and School heads (n =2). Heads of departments, School heads and teachers were interviewed individually; students and prefects were interviewed in groups. Prefects were observed on duty within stipulated times such as study time, meal hours, sports times and assembly times. In conducting the study, we used semi-structured interviews whereby we used an interview guide and also prompted and probed the participants to get more information. Focus groups were used in this study where we discussed the topic on democratization of schools through the use of prefects. Xxxxxx (1997) states that through focus groups, different types of data can be gained because of pronounced interaction of different people within a social group. One advantage of using focus gro...
Sample 1
AutoNDA by SimpleDocs
Research Sites. The study employed six face-to-face interviews with the school principals. As Xxxx (2003) stated, compared to telephone or e-mail interviews, conducting face-to-face interviews makes possible to obtain more “thoughtful” responses When there is a lack of non-verbal and visual interaction this makes interviewing process unnatural, thus, it may have an impact on the quality of participants’ answers. The selection of these schools was based on convenience sampling. For a researcher, this sampling means the accessibility of the study participants in terms of their geographical locations (Dörnyei, 2007). When considering study participants’ and the researchers’ work schedule, it was decided to conduct the study in the schools of two city centers: Karaganda is the city where the researcher lives and works in, while Nur-Sultan is the capital city, which is only two hours away so easy to travel to. It also has to be mentioned that the type of the schools was purposefully selected, since this research considers the views of the principals working in the selective schools with no application fees. Thus, the study was conducted in the secondary schools for gifted children that accept students on a competitive basis and teach them from grades 7 to 12. The number of the students in these schools varies from 300 to 700.
Sample 1

Related to Research Sites

  • Research Use The Requester agrees that if access is approved, (1) the PI named in the DAR and (2) those named in the “Senior/Key Person Profile” section of the DAR, including the Information Technology Director and any trainee, employee, or contractor1 working on the proposed research project under the direct oversight of these individuals, shall become Approved Users of the requested dataset(s). Research use will occur solely in connection with the approved research project described in the DAR, which includes a 1-2 paragraph description of the proposed research (i.e., a Research Use Statement). Investigators interested in using Cloud Computing for data storage and analysis must request permission to use Cloud Computing in the DAR and identify the Cloud Service Provider (CSP) or providers and/or Private Cloud System (PCS) that they propose to use. They must also submit a Cloud Computing Use Statement as part of the DAR that describes the type of service and how it will be used to carry out the proposed research as described in the Research Use Statement. If the Approved Users plan to collaborate with investigators outside the Requester, the investigators at each external site must submit an independent DAR using the same project title and Research Use Statement, and if using the cloud, Cloud Computing Use Statement. New uses of these data outside those described in the DAR will require submission of a new DAR; modifications to the research project will require submission of an amendment to this application (e.g., adding or deleting Requester Collaborators from the Requester, adding datasets to an approved project). Access to the requested dataset(s) is granted for a period of one (1) year, with the option to renew access or close-out a project at the end of that year. Submitting Investigator(s), or their collaborators, who provided the data or samples used to generate controlled-access datasets subject to the NIH GDS Policy and who have Institutional Review Board (IRB) approval and who meet any other study specific terms of access, are exempt from the limitation on the scope of the research use as defined in the DAR.

  • Sites Sites shall mean the locations set forth in the Contract Documentation.

  • Development Area 10.4. The Development Area shall encompass all Deposits to be produced.

  • Collaboration We believe joint effort toward common goals achieves trust and produces greater impact for L.A. County’s youngest children and their families.

  • Develop programs 1) The Employer will develop and implement health promotion and health education programs, subject to the availability of resources. Each Appointing Authority will develop a health promotion and health education program consistent with the Minnesota Management & Budget policy. Upon request of any exclusive representative in an agency, the Appointing Authority shall jointly meet and confer with the exclusive representative(s) and may include other interested exclusive representatives. Agenda items shall include but are not limited to smoking cessation, weight loss, stress management, health education/self-care, and education on related benefits provided through the health plan administrators serving state employees.

  • Research Design The data generated by excavations at the prehistoric site(s) will be used to examine at least three topics: (1) chronology; (2) technology; and (3) subsistence practices. Insights into changing patterns of community organization may also be granted, as may insights into changes in social organization. The data recovered will then be compared to data from other regional sites.

  • Research Project 3.1 These Materials and Data will be used by Recipient's PI solely in connection with the Research Project, as named and described in the attached research application (insert Research Project name below):

  • Development Activities The Development activities referred to in item “b” of paragraph 3.1 include: studies and projects of implementation of the Production facilities; drilling and completion of the Producing and injection xxxxx; and installation of equipment and vessels for extraction, collection, Treatment, storage, and transfer of Oil and Gas. The installation referred to in item “c” includes, but is not limited to, offshore platforms, pipelines, Oil and Gas Treatment plants, equipment and facilities for measurement of the inspected Production, wellhead equipment, production pipes, flow lines, tanks, and other facilities exclusively intended for extraction, as well as oil and gas pipelines for Production Outflow and their respective compressor and pumping stations.

  • Research Support opioid abatement research that may include, but is not limited to, the following:

  • Clinical Trials The studies, tests and preclinical and clinical trials conducted by or on behalf of, or sponsored by, the Company, or in which the Company has participated, that are described in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, or the results of which are referred to in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, were and, if still pending, are being conducted in all material respects in accordance with protocols, procedures and controls pursuant to, where applicable, accepted professional and scientific standards for products or product candidates comparable to those being developed by the Company and all applicable statutes, rules and regulations of the FDA, the EMEA, Health Canada and other comparable drug and medical device (including diagnostic product) regulatory agencies outside of the United States to which they are subject; the descriptions of the results of such studies, tests and trials contained in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus do not contain any misstatement of a material fact or omit a material fact necessary to make such statements not misleading; the Company has no knowledge of any studies, tests or trials not described in the Disclosure Package and the Prospectus the results of which reasonably call into question in any material respect the results of the studies, tests and trials described in the Registration Statement, the Time of Sale Disclosure Package or Prospectus; and the Company has not received any notices or other correspondence from the FDA, EMEA, Health Canada or any other foreign, state or local governmental body exercising comparable authority or any Institutional Review Board or comparable authority requiring or threatening the termination, suspension or material modification of any studies, tests or preclinical or clinical trials conducted by or on behalf of, or sponsored by, the Company or in which the Company has participated, and, to the Company’s knowledge, there are no reasonable grounds for the same. Except as disclosed in the Registration Statement, the Time of Sale Disclosure Package and the Prospectus, there has not been any violation of law or regulation by the Company in its respective product development efforts, submissions or reports to any regulatory authority that could reasonably be expected to require investigation, corrective action or enforcement action.

Time is Money Join Law Insider Premium to draft better contracts faster.